
- “According to a recent study, 67% of patients whose specialty drugs were rejected under step therapy did not receive an alternate drug within a 30-day window,”
- . “In these cases, patients may experience disease progression, a serious risk for patients dealing with life-threatening conditions such as cancer.”
- “For patients with complex conditions, such as rheumatoid arthritis, it is critical to ensure they have timely access to medications that can put their disease into a low disease state or medicated remission,”
- . “And for those patients that meet one of the criteria listed in SB 526 it could mean stopping their condition from causing irreversible damage and joint destruction.”
- Step therapy frequently “delays access to optimal therapy, while potentially exacerbating a patient’s condition,” they wrote. “The relationship that a patient, especially those with chronic illnesses, has with their doctor is vital.”
- “This is a sensible bill that ensures the wellness of Oregon’s most vulnerable citizens by protecting the individualized treatment decisions that are made between the provider and the patient."